Connexin43 peptide, TAT-Cx43(266–283), selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

BACKGROUND: Malignant gliomas are the most frequent primary brain tumors and remain among the most incurable cancers. Although the role of the gap junction protein, connexin43 (Cx43), has been deeply investigated in malignant gliomas, no compounds have been reported with the ability to recapitulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaraíz-Rodríguez, Myriam, Talaverón, Rocío, García-Vicente, Laura, Pelaz, Sara G, Domínguez-Prieto, Marta, Álvarez-Vázquez, Andrea, Flores-Hernández, Raquel, Sin, Wun Chey, Bechberger, John, Medina, José M, Naus, Christian C, Tabernero, Arantxa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158688/
https://www.ncbi.nlm.nih.gov/pubmed/31883012
http://dx.doi.org/10.1093/neuonc/noz243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158688/
https://www.ncbi.nlm.nih.gov/pubmed/31883012
http://dx.doi.org/10.1093/neuonc/noz243

Ejemplares similares